The Evolution of access to essential medicines for the treatment of HIV/AIDS


On 2 October 2026 in Washington, D.C., IFPMA delivered a statement on reforming the global health architecture as a special briefing session following the 78th Regional Committee for the Americas. IFPMA welcomes this discussion on global health architecture reform and emphasizes the need for an architecture that fosters innovation, strengthens health systems, and forges partnerships...
Read moreOn 26 August, IFPMA delivered a statement on the special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus at the 76th session off the WHO Regional Committee for Africa in Addis Ababa. Marking the 100th day after the Bundibugyo outbreak was declared, the global pharmaceutical industry underscores its commitment and track...
Read moreOn 26 August 2026, IFPMA delivered a statement on a strategy for financing the future of health in the WHO African Region, 2026-2036, during the 76th WHO Regional Committee for Africa in Addis Ababa, Ethiopia. IFPMA welcomes the strategy for financing the future of health in the WHO African Region and its focus on sustainable,...
Read more